Medical device maker Guidant Corp. announced Thursday that an arbitration panel found that one of its stent products infringed on Miami-based Cordis Corp.'s patents. Guidant said it will likely request a review of the panel's decision, but if the decision is upheld, it will have to pay Cordis, a unit of Johnson & Johnson, $425 million.
June 06, 2003 at 12:00 AM
1 minute read
The original version of this story was published on Law.Com
Presented by BigVoodoo
Recognizing innovation in the legal technology sector for working on precedent-setting, game-changing projects and initiatives.
Legalweek New York explores Business and Regulatory Trends, Technology and Talent drivers impacting law firms.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Cozen O Connor is seeking an associate with at least three years of experience defending clients in employment litigation matters to join th...
Busy and growing general practice seeks NY admitted associate, with 3+ years experience in divorce/family law. The ideal candidate will be a...
Boutique downtown Manhattan firm seeking an experienced litigation associate with experience in landlord-tenant and real estate litigation. ...
Snyder Sarno D'Aniello Maceri & daCosta would like to announce that...
COLE SCHOTZ P.C. WELCOME HONORABLE GARRY S. ROTHSTADT, J.A.D. (RET.)
GREENBAUM ROWE SMITH & DAVIS LLP would like to announce that...
